JPS6256336A - Production of crystallized cao-al2o3-p2o5 glass - Google Patents

Production of crystallized cao-al2o3-p2o5 glass

Info

Publication number
JPS6256336A
JPS6256336A JP60194593A JP19459385A JPS6256336A JP S6256336 A JPS6256336 A JP S6256336A JP 60194593 A JP60194593 A JP 60194593A JP 19459385 A JP19459385 A JP 19459385A JP S6256336 A JPS6256336 A JP S6256336A
Authority
JP
Japan
Prior art keywords
crystallization
glass
al2o3
cao
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60194593A
Other languages
Japanese (ja)
Inventor
Akira Watanabe
明 渡辺
Yoshimitsu Takeuchi
武内 祥光
Seiji Kihara
木原 誠治
Makoto Koto
光藤 誠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Krosaki Harima Corp
Original Assignee
Kyushu Refractories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyushu Refractories Co Ltd filed Critical Kyushu Refractories Co Ltd
Priority to JP60194593A priority Critical patent/JPS6256336A/en
Publication of JPS6256336A publication Critical patent/JPS6256336A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To produce titled glass adequate as a dental material without having defects such as cracks by subjecting a glassy casting formed by adding F atoms to the compsn of a ternary component system of CaO-Al2O3-P2O5 to multiple stages of crystallization treatments while heating up the casting. CONSTITUTION:F atoms are added to a raw material mixtue of the compsn. composed of 10-60wt% CaO, 5-35wt% Al2O3 and 25-85wt% P2O5 at <=3pts. wt. by 100pts.wt. in total of the above-mentioned compsn. The mixture is melted and cast to produce the glassy casting. The glassy casting is subjected to >=2 stages of the crystallization treatment while the temp. is gradually increased between the softening point thereof and the crystallization temp. of calcium phosphate. The melting of Al2O3 at the lower temp. is made possible by the incorporation of the F atoms into the compsn.; in addition, the cleaning up of the raw material is made easy and the time when the glass is kept melted is shorter; further the formation of crystal nuclei is accelerated in the crystallization stage of the glass. The titled glass having no voids and cracks is obtd. by multiple stages of the crystallization treatments.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は歯科材料や人工骨材料等として最適であるリン
酸カルシウム結晶を含有するCaO−Al2O3P20
B結晶化ガラス医用材料の製造方法に関するものである
Detailed Description of the Invention [Industrial Field of Application] The present invention provides a CaO-Al2O3P20 material containing calcium phosphate crystals, which is most suitable for dental materials, artificial bone materials, etc.
This invention relates to a method for producing B-crystallized glass medical material.

〔従来の技術〕[Conventional technology]

近年セラミックの応用範囲の拡大は目ざましく医用分野
にまで適用が及んでおり、従来は金属、プラスチックが
主に使用されて来た医用材料、例えば人工歯根等へもセ
ラミックの応用が試みられている。
In recent years, the range of applications for ceramics has expanded rapidly, reaching the medical field, and attempts are being made to apply ceramics to medical materials, such as artificial tooth roots, for which metals and plastics have traditionally been used. .

本発明者らは生体に対する親和性を有するセラミック材
料を探し出し、それを任意の形状に自由にかつ高精度に
成形して高強度セラミックを製造する方法に関して研究
を重ねた結果、リン酸カルシウム系材料を素材として選
択することにより、それが可能であることを見出し、そ
れについて鋭意研究を重ねている。
The present inventors searched for a ceramic material that has an affinity for living organisms, and as a result of repeated research into a method for manufacturing high-strength ceramic by freely and highly precisely molding it into any shape, they found that a calcium phosphate-based material was used as a raw material. We have discovered that this is possible by selecting the appropriate method, and have been conducting extensive research on it.

この優れた特徴を有するリン酸カルシウム系材料も、一
旦ガラス化し結晶化させた際に、ガラスと結晶との比重
差に基づく内部欠陥が発生し、そのため機械的強度が低
下したり、細面などが侵入しやすくなる。
Even with calcium phosphate materials that have these excellent characteristics, once they are vitrified and crystallized, internal defects occur due to the difference in specific gravity between the glass and the crystal, resulting in a decrease in mechanical strength and the intrusion of fine surfaces. It becomes easier.

例えば、カルシウムとリンとの原子比Ca / Pが0
.48のリン酸カルシウムガラスの比重は2.63であ
り、これを熱処理して結晶化するとCaO・P2O6が
生成する。このCaO−PzOs結晶の真比重は2.8
5であり、ガラスの比重よりかなり大きい。ところが結
晶化は表面失透機構で進行するため、結晶化に伴なう体
積減少はほとんどない。
For example, the atomic ratio of calcium and phosphorus, Ca/P, is 0.
.. The specific gravity of calcium phosphate glass No. 48 is 2.63, and when it is heat-treated and crystallized, CaO.P2O6 is produced. The true specific gravity of this CaO-PzOs crystal is 2.8
5, which is considerably larger than the specific gravity of glass. However, since crystallization proceeds by a surface devitrification mechanism, there is almost no volume reduction accompanying crystallization.

ところが結晶化によって比重が増加するということは体
積が減少することを意味し、全体の体積が変化しなけれ
ば、結晶内部には比重の増加に相当する体積減少分の空
隙が発生し、これがクラックやボアのような内部欠陥と
なる。この内部欠陥のため結晶体の強度は欠陥のないも
のに比べて低下してしまうのである。また、ボアなどの
発生の様子はガラスのカルシウムとリンの原子比、結晶
化温度、結晶化時間などの種々の要因に左右されるため
、機械的強度のバラツキも大きくなることも避けられな
い。
However, an increase in specific gravity due to crystallization means a decrease in volume, and if the overall volume does not change, voids corresponding to the decrease in volume corresponding to the increase in specific gravity will occur inside the crystal, which will cause cracks. or internal defects such as bores. Because of these internal defects, the strength of the crystal is lower than that of a crystal without defects. Furthermore, since the appearance of bores and the like depends on various factors such as the atomic ratio of calcium and phosphorus in the glass, crystallization temperature, and crystallization time, it is inevitable that the mechanical strength will vary widely.

この内部欠陥は、添加物を加えたり、結晶化の方法に工
夫を加えたバルク・クリスタリゼーシコン機構による結
晶化でも結晶化の体積収縮が表面失透機構による場合よ
りや\大きいので内部欠陥の発生する程度は小さいけれ
ども、やはり同様に起こるのである。
These internal defects are caused by the fact that even when crystallization is carried out by the bulk crystallization mechanism by adding additives or devising the crystallization method, the volume contraction during crystallization is larger than that by the surface devitrification mechanism. Although the degree of occurrence is small, it still occurs in the same way.

上述の欠点を解消するためには、結晶化前後の比重差を
なくすればよいわけで、本発明者らはリン酸カルシウム
の生体親和性と結晶化の際の体積収縮の無いという特徴
を損なわずに内部欠陥を生じないような方法について種
々検討した結果、CaO−Al2O3−P2053成分
系結晶化ガラスを採用することによって、上記問題を解
決することに成功した。
In order to eliminate the above-mentioned drawbacks, it is sufficient to eliminate the difference in specific gravity before and after crystallization, and the present inventors have developed a method that does not impair the biocompatibility of calcium phosphate and the characteristics of no volume contraction during crystallization. As a result of various studies on methods that do not cause internal defects, we succeeded in solving the above problem by employing CaO-Al2O3-P205 ternary crystallized glass.

〔発明が解決しようとする問題〕[Problem that the invention seeks to solve]

しかし、結晶化前後の比重差を小さくするためにはある
程度以上のAl2O3量が必要であるが、Al2O3の
量を増すに従って次第に融点が上昇してしまい、添加し
たAl2O3を完全に溶融するためには、かなり高温に
しなければならなくなる。
However, in order to reduce the difference in specific gravity before and after crystallization, a certain amount of Al2O3 is required, but as the amount of Al2O3 increases, the melting point gradually increases, and in order to completely melt the added Al2O3, , it would have to be heated to a fairly high temperature.

しかし、溶融のために温度を上げるとリン酸成分の窯発
が顕著になるという不都合が生ずる。
However, when the temperature is increased for melting, a disadvantage arises in that the phosphoric acid component is significantly released in the kiln.

またAl2O3の量が多くなるとガラスの軟化点もリン
酸カルシウムの結晶化温度も上昇し、比重差を補正する
はずのAl2O3・P2O5の結晶が十分に生成せず、
そのため結晶化前後の比重差による空隙やクラックの発
生が防げないという問題が発生するのである。
Furthermore, when the amount of Al2O3 increases, the softening point of the glass and the crystallization temperature of calcium phosphate also rise, and the Al2O3/P2O5 crystals that should compensate for the difference in specific gravity are not sufficiently formed.
Therefore, a problem arises in that the generation of voids and cracks due to the difference in specific gravity before and after crystallization cannot be prevented.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らはCaO−Al2O3P2O153成分系の
組成にフッ素原子を含有させることによりAl2O3の
溶解度を増し、さらに結晶化の際にガラス質鋳造体の軟
化点とリン酸カルシウムの結晶化温度との間の温度で次
第に温度を上げながら2段階以上の結晶化処理を行なう
ことにより上記の問題点を解消し本発明を完成させたの
である。
The present inventors increased the solubility of Al2O3 by including fluorine atoms in the composition of the CaO-Al2O3P2O15 3-component system, and furthermore, during crystallization, the temperature between the softening point of the glassy casting and the crystallization temperature of calcium phosphate was increased. By performing two or more stages of crystallization treatment while gradually increasing the temperature, the above problems were solved and the present invention was completed.

〔作用〕[Effect]

本発明による製造方法の特徴はCaO10〜60重量%
、Al2035〜35重量%、P 20 s 25〜8
5重量%なる組成範囲(7)CaO−Al2O3−P2
0S系素材においてCaOSAl2O3およびP2O5
の合量100重量部に対しF原子として3重量部以下を
含有せしめ、溶融、鋳造後、ガラス質鋳造体の軟化点と
リン酸カルシウムの結晶化温度との間の温度で次第に温
度を上げながら2段階以上の結晶化処理を行なうことに
ある。
The feature of the production method according to the present invention is that CaO is 10 to 60% by weight.
, Al2035-35% by weight, P20s 25-8
Composition range of 5% by weight (7) CaO-Al2O3-P2
CaOSAl2O3 and P2O5 in OS-based materials
3 parts by weight or less of F atoms are contained per 100 parts by weight of the total amount of F atoms, and after melting and casting, it is heated in two stages while gradually increasing the temperature between the softening point of the glassy casting and the crystallization temperature of calcium phosphate. The purpose is to perform the above crystallization treatment.

上記組成のガラスを結晶化した場合に生成する結晶は主
にCaO−P20aと2CaCIPz○6とそれにAl
2O3・P2O5である。その真比重はそれぞれ順に2
.85.3.09、および2.59となっており、Al
2O3・P20E+の比重が他の2種のリン酸カルシウ
ム結晶よりかなり低い。
When glass with the above composition is crystallized, the crystals produced are mainly CaO-P20a, 2CaCIPz○6, and Al.
2O3・P2O5. Their true specific gravity is 2 in order
.. 85.3.09, and 2.59, and Al
The specific gravity of 2O3.P20E+ is considerably lower than the other two types of calcium phosphate crystals.

例えば、Ca 021.8重量%、Al2O39,3重
量%、P20r、 68.9重量%の組成のガラスの比
重は2.64であり、このガラスを結晶化させる際に、
生成する結晶が上記2種のリン酸カルシウムのみであれ
ば、その結晶の比重がガラスの比重より大きいため体積
収縮を起こして外形に歪が生ずるか、あるいは体積収縮
がなければ、結晶内部にボアなどの欠陥が生ずる。しか
しガラス中にAl2O3を含むため比重の小さいAl2
O3・P2O6が同時に生成する。Al2O3・P2O
6の結晶を十分に生成させると、その体積膨張により、
リン酸カルシウムによる体積収縮を補なうことになり、
結晶化後の比重は2.65となり、比重差はほとんどな
くなり、内部欠陥は全(見られなくなる。
For example, a glass with a composition of 21.8% by weight of Ca, 9.3% by weight of Al2O3, and 68.9% by weight of P20r has a specific gravity of 2.64, and when this glass is crystallized,
If the crystals formed are only the above two types of calcium phosphate, the specific gravity of the crystals is greater than the specific gravity of the glass, causing volumetric contraction and distortion of the external shape, or, if there is no volumetric contraction, there may be holes such as holes inside the crystals. Defects occur. However, since Al2O3 is included in the glass, Al2 has a low specific gravity.
O3 and P2O6 are generated simultaneously. Al2O3・P2O
When enough crystals of 6 are formed, due to their volumetric expansion,
This will compensate for the volumetric contraction caused by calcium phosphate,
The specific gravity after crystallization is 2.65, the difference in specific gravity almost disappears, and all internal defects disappear.

しかしCaO/P2O5のモル比の範囲によってはガラ
スの結晶化前後の比重差を無くすためにはAl2O3の
量を多くしなければならない場合がある。しかし、Al
2O3の量を増すに従って次第に融点が上昇してしまい
、添加したAl2O3を完全に溶融するためには、かな
り高温にしなければならなくなる。しかし、溶融のため
に温度を上げるとリン酸成分の蒸発が顕著になるという
不都合が生ずるのである。そこで CaO−Al2O3
−P20s 3成分系素材中にF原子を含有させるとよ
り低温でのAl2O3の溶解が可能となるのである。な
お含有するF原子は結晶化に際してはガラス中に残り結
晶化前後の比重差には影響しない。
However, depending on the range of the CaO/P2O5 molar ratio, it may be necessary to increase the amount of Al2O3 in order to eliminate the difference in specific gravity before and after crystallization of the glass. However, Al
As the amount of 2O3 increases, the melting point gradually increases, and in order to completely melt the added Al2O3, a considerably high temperature is required. However, when the temperature is raised for melting, the evaporation of the phosphoric acid component becomes significant, which is a disadvantage. So CaO-Al2O3
-P20s When F atoms are included in the three-component material, Al2O3 can be dissolved at lower temperatures. The F atoms contained remain in the glass during crystallization and do not affect the difference in specific gravity before and after crystallization.

もちろんAl2O3量がそれほど多(ない領域であって
もF原子の含有は試料の溶融の助けになるので含有して
いることが望ましい。
Of course, even in a region where the amount of Al2O3 is not so large, it is desirable to contain F atoms since it helps in melting the sample.

またF原子の含有は溶融した原料の清澄化が容易となり
、溶融している時間が短くなり、さらにガラスの結晶化
の際に結晶核の核形成を促進する作用もあり、製品の強
度向上に貢献するという利点も合わせ持つ。
In addition, the inclusion of F atoms makes it easier to clarify the molten raw material, shortens the melting time, and also has the effect of promoting the formation of crystal nuclei during glass crystallization, which improves the strength of the product. It also has the advantage of contributing.

一方Al2O3が存在することはCaOHP2O5と2
CaO−P2O5の結晶化温度を上昇させ、もともとあ
ったAl2O3・P2O5の結晶化温度との開きをさら
に大きくする。従って2種のリン酸カルシウムの結晶化
温度付近で結晶化させた場合は2種のリン酸カルシウム
の結晶が主として生成してしまい、Al2O3・P2O
5の結晶はあまり生成せず、その体積膨張による比重差
の補填効果が発揮されないのである。
On the other hand, the presence of Al2O3 means that CaOHP2O5 and 2
The crystallization temperature of CaO-P2O5 is increased to further increase the difference from the crystallization temperature of Al2O3.P2O5, which was originally present. Therefore, if crystallization is performed near the crystallization temperature of two types of calcium phosphate, two types of calcium phosphate crystals will be mainly formed, and Al2O3・P2O
The crystals of No. 5 do not form much, and the effect of compensating for the difference in specific gravity due to their volumetric expansion is not exhibited.

この難点を解決するために、ガラスの軟化点よりや\高
い温度であって、リン酸カルシウムの結晶化温度より低
い温度で処理して、まずリン酸アルミニウムの結晶を生
成させ、次いで、リン酸カルシウムの結晶化温度に上げ
てリン酸カルシウムの結晶化を完成させる方法を採用す
ることによって、結晶内でのリン酸アルミニウムによる
体積補填効果を十分に発揮させることができる。この結
晶化の操作を上記の2段階でなく、ガラスの軟化点とリ
ン酸カルシウムの結晶化温度との間の温度で次第に温度
を上げながら3段階以上行なうことも可能である。さら
にガラスの軟化点とリン酸カルシウムの結晶化温度との
間で連続的に温度を上げて行ってもよい。
In order to solve this problem, we first produced crystals of aluminum phosphate by processing at a temperature slightly higher than the softening point of glass and lower than the crystallization temperature of calcium phosphate, and then crystallized calcium phosphate. By employing a method of raising the temperature to complete the crystallization of calcium phosphate, it is possible to fully exhibit the volume compensation effect of aluminum phosphate within the crystal. It is also possible to carry out this crystallization operation in three or more stages while gradually increasing the temperature between the softening point of the glass and the crystallization temperature of calcium phosphate, instead of the above two stages. Furthermore, the temperature may be raised continuously between the softening point of the glass and the crystallization temperature of calcium phosphate.

この多段階処理による結晶化によって、ガラスと結晶と
の間の比重差を無くして、結晶内の欠陥の発生を防ぐと
同時に、低温での結晶化によって結晶内部にも結晶核が
生成し、表面から結晶が発達する表面失透性を弱め、ク
ラックの発生を防止し、さらに高温での結晶化処理時間
が短くなることで、製品の軟化変形を少なくできる効果
も生ずる。
This multi-step crystallization process eliminates the difference in specific gravity between the glass and the crystal, preventing the formation of defects within the crystal. At the same time, crystallization at low temperatures also generates crystal nuclei inside the crystal, and the surface By weakening the surface devitrification that causes crystals to develop, preventing the occurrence of cracks, and shortening the crystallization time at high temperatures, it also has the effect of reducing softening and deformation of the product.

〔発明の構成〕[Structure of the invention]

本発明の出発原料は酸化カルシウムあるいは水酸化カル
シウム、炭酸カルシウム、蓚酸カルシウムなど焼成によ
つてCaOを生成するカルシウム含有化合物と、リン酸
、ポリリン酸など同じ(焼成によってリンの酸化物を生
成するリン含有化合物およびアルミナ、水酸化アルミニ
ウムなど焼成してAl2O3となるようなアルミニウム
含有化合物が用いられる。またリン酸カルシウム、アパ
タイト類、リン酸アルミニウム、アルミン酸カルシウム
なども使用出来る。またフッ素源としてはフッ化カルシ
ウム、フッ化アルミニウム、フッ素含有アパタイトなど
が利用できるが、昇華のないフッ化カルシウムが最も適
している。
The starting materials of the present invention are calcium-containing compounds that produce CaO upon calcination, such as calcium oxide, calcium hydroxide, calcium carbonate, and calcium oxalate, and phosphoric acid, polyphosphoric acid, etc., which produce phosphorus oxides upon calcination. Aluminum-containing compounds and aluminum-containing compounds that become Al2O3 when fired, such as alumina and aluminum hydroxide, are used.Also, calcium phosphate, apatites, aluminum phosphate, calcium aluminate, etc. can be used.Also, as a fluorine source, calcium fluoride is used. , aluminum fluoride, fluorine-containing apatite, etc. can be used, but calcium fluoride, which does not sublimate, is the most suitable.

カルシウム、ワン、アルミニウムおよびフッ素を含有す
る化合物のそれぞれ1種あるいは2這以上を選び、ガラ
スの組成をCaO10〜60重量%、Al2O35〜3
5重量%、P 20 s 25〜85重量%の範囲に、
またF原子としてはCa O,Al2O3、P2O6の
合量1圓重量部に対し、3重量部以下とする。
One or more compounds containing calcium, aluminum, aluminum, and fluorine are selected, and the composition of the glass is set to 10 to 60% by weight of CaO and 35 to 3% of Al2O.
5% by weight, P20s in the range of 25-85% by weight,
Further, the F atom should be 3 parts by weight or less per 1 part by weight of the total amount of CaO, Al2O3, and P2O6.

CaO60重量%以上あるいはP 20625重量%未
満では溶融温度が高くなり、かつガラス化しない。逆に
CaO10重量%未満またはP 20 s 85重量%
以上では溶融温度が低下すると同時にガラス化も容易に
なるが、結晶化処理が難しくなり、かつ過剰のリン酸が
遊離して化学的に不安定となり好マしくない。一方アル
ミナの含有量が35重量%を越えると溶融温度が高くな
り、また5重量%未満とするとAl2O3・P2O5の
結晶が生成しないか生成量が少な(、ボアなどの内部欠
陥の発生が防げないので好ましくない。一方F原子の含
有量が3重量部以上ではCaF2の結晶が析出し、この
比重が大きいためAl2O3の効果がなくなり好ましく
ない。
If CaO is 60% by weight or more or P is less than 20625% by weight, the melting temperature becomes high and vitrification does not occur. Conversely, less than 10% by weight of CaO or 85% by weight of P 20 s
In this case, the melting temperature is lowered and vitrification becomes easier, but the crystallization process becomes difficult and excess phosphoric acid is liberated, resulting in chemical instability, which is not preferable. On the other hand, if the alumina content exceeds 35% by weight, the melting temperature will become high, and if it is less than 5% by weight, Al2O3/P2O5 crystals will not form or will be formed in small amounts (and the generation of internal defects such as bores cannot be prevented). On the other hand, if the F atom content is 3 parts by weight or more, CaF2 crystals will precipitate, and the specific gravity of these crystals will be large, so that the effect of Al2O3 will be lost, which is not preferable.

本発明のリン酸カルシウム系ガラスは基本的にはCa 
s A l及びPの3成分から構成されるが、本発明の
方法により製造された結晶化ガラスを歯冠材料として使
用する場合は、天然の歯牙と全(同じ色沢とするために
着色剤成分を加えることも出来る。着色剤成分を加える
場合にはZn、Fe。
The calcium phosphate glass of the present invention basically consists of Ca
It is composed of three components: Al and P. However, when using the crystallized glass produced by the method of the present invention as a dental crown material, it is necessary to use the same coloring agent as natural teeth. It is also possible to add other components.If a colorant component is added, Zn, Fe.

Mn、 W、 Ce、 Ti、 Ni、 Go、 Cr
、 Vの酸化物の中から選ばれた1種あるいは2種以上
を使用し、特に2種以上を組合せて使用することが好ま
しい。その添加量は Cab−Altos−P20S3
成分系酸化物の100重量部に対して0.01〜15重
量部とする。
Mn, W, Ce, Ti, Ni, Go, Cr
, V oxides are used, and it is particularly preferable to use two or more of them in combination. The amount added is Cab-Altos-P20S3
The amount is 0.01 to 15 parts by weight per 100 parts by weight of the component oxide.

原料配合は秤量後よく混合し、容器に入れ90口°C以
上、好ましくは1000〜1700″Cに加熱して溶融
する。溶融は1800@C以上となるとリン成分の蒸発
が始まるので注意が必要である。本発明の場合にはF原
子の存在により、上記温度範囲でAl2O3が十分融解
するはずである。
After weighing the raw materials, mix well, place in a container, and heat to 90°C or higher, preferably 1000 to 1700"C to melt. Care must be taken when melting at 1800°C or higher, as the phosphorus component will begin to evaporate. In the case of the present invention, Al2O3 should be sufficiently melted in the above temperature range due to the presence of F atoms.

溶融終了後冷却ガラス化する。続いて再度溶融して鋳造
するのであるが、最初の溶融物を一旦冷却ガラス化せず
、直接鋳造してもよい。本発明のCaO−Al2O3−
P2O53成分系材料の場合には、鋳造成形は金属の歯
科材料において行なわれるロストワックス法が適してい
る。鋳造型の予熱温度は8009C以下、好ましくは2
00〜800°Cの範囲で鋳造型の材質、ガラス質の組
成により適宜選択される。
After the melting is completed, it is cooled and vitrified. Subsequently, it is melted and cast again, but the first melt may be directly cast without being cooled and vitrified. CaO-Al2O3- of the present invention
In the case of P2O5 tricomponent based materials, the lost wax method, which is carried out on metal dental materials, is suitable for casting. The preheating temperature of the casting mold is 8009C or less, preferably 2
The temperature is appropriately selected within the range of 00 to 800°C depending on the material of the casting mold and the composition of the glass.

このようにして鋳造された鋳造物はガラス質である。こ
のガラス質の材料に適切な熱処理を加えて結晶化ガラス
とする際の結晶化処理方法に本発明の製造方法の一つの
特徴がある。本発明による3成分系結晶化ガラスの結晶
化方法は次の通りである。ロストワックス法などにより
成形された成形体は通常埋没型のま\電気炉などの適当
な加熱装置中で加熱される。この際の加熱温度はまず示
差熱分析などを利用して、ガラスの軟化点とリン酸カル
シウムの結晶化温度を求める。まずガラスの軟化点より
や−高い温度で結晶化し、次いで温度を少し上げ再び結
晶化処理を行なう。こうして温度を上げなから結晶化処
理し、最後はリン酸カルシウムの結晶化温度で処理する
。この処理段階は2段階以上何段階でもよいが、操作性
の点から2〜4段階が好ましい。処理時間は全体で5〜
50hrとする。
The casting thus cast is glassy. One of the features of the manufacturing method of the present invention is the crystallization treatment method in which this glassy material is subjected to appropriate heat treatment to produce crystallized glass. The method for crystallizing the three-component crystallized glass according to the present invention is as follows. A molded body formed by a lost wax method or the like is usually heated in a suitable heating device such as an immersion mold or an electric furnace. As for the heating temperature at this time, first, the softening point of the glass and the crystallization temperature of calcium phosphate are determined using differential thermal analysis. First, the glass is crystallized at a temperature slightly higher than the softening point of the glass, and then the temperature is slightly raised and the crystallization process is performed again. In this way, the crystallization process is performed without raising the temperature, and the final process is performed at the crystallization temperature of calcium phosphate. The number of stages of this treatment may be two or more, but from the viewpoint of operability, two to four stages are preferred. Total processing time is 5~
It will be 50 hours.

〔実施例〕〔Example〕

実施例 1 炭酸カルシウム粉末、アルミナ粉末、正リン酸およびフ
ッ化カルシウム粉末を最終組成がCaO13,6重量%
、Al20328.0重量%、P 20 r、 58.
4重量%、CaO+AlzO3+P2O6100重量部
に対しF原子が1.5重量部となるように秤量し、よく
混練した後白金ルツボ中1600@Cでlhr熔融して
、連結歯冠を埋没した型に圧迫鋳造し、冷却ガラス化し
た。得られたガラスを埋没型のま\電気炉中で688℃
で2hr、690℃で2hr、次いで700℃で10h
r処理し結晶化した。
Example 1 Calcium carbonate powder, alumina powder, orthophosphoric acid, and calcium fluoride powder with a final composition of 13.6% by weight CaO
, Al20328.0% by weight, P 20 r, 58.
4% by weight, CaO + AlzO3 + P2O6 100 parts by weight, F atoms were weighed so that 1.5 parts by weight were mixed, thoroughly kneaded, melted in a platinum crucible at 1600@C for lhr, and pressure cast into a mold in which the connecting crown was embedded. It was then cooled and vitrified. The obtained glass was kept buried in an electric furnace at 688°C.
2 hours at 690℃, then 10 hours at 700℃
It was treated with r and crystallized.

得られた結晶体は白色半透明で、結晶体の微細組織を顕
微鏡により観察したところボアやクラッタなどの欠陥は
全(見られなかった。結晶体のX線回折の結果は結晶体
中にはCaO・P2O6とAl2O3・P2O6が存在
した。またガラスの比重は2.64で、結晶体の比重は
2゜65であった。
The obtained crystal was white and translucent, and when the microstructure of the crystal was observed under a microscope, no defects such as bores or clutter were observed. CaO.P2O6 and Al2O3.P2O6 were present.The specific gravity of the glass was 2.64, and the specific gravity of the crystal was 2.65.

比較例 1 フッ化カルシウムを含有しない以外は実施例1と同様の
材料を溶融しようとしたが、1600℃では原料が完全
には溶融しないので、温度を1850℃まで上げるとや
っと溶融したが、融液が清澄となるまで加熱を続ける間
にリン酸成分が蒸発し、次第に結晶が析出しはじめた。
Comparative Example 1 An attempt was made to melt the same material as in Example 1 except that it did not contain calcium fluoride, but the raw material did not melt completely at 1600°C, so it finally melted when the temperature was raised to 1850°C, but the melting failed. While heating was continued until the liquid became clear, the phosphoric acid component evaporated and crystals gradually began to precipitate.

比較例 2 実施例1と全く同じ組成の原料を溶融、鋳造後700℃
、10hrで一段階で結晶化した。
Comparative Example 2 Raw materials with exactly the same composition as Example 1 were melted and cast at 700°C.
, crystallized in one step for 10 hr.

得られた結晶化ガラスも白色半透明ではあったが、結晶
体にはAl2O3・P2O5の結晶は少なく、ガラスの
比重は2.64で、結晶体の比重は2.70で、結晶内
部にはボアがわずか見られた。
The obtained crystallized glass was also white and translucent, but there were few Al2O3/P2O5 crystals in the crystal, the specific gravity of the glass was 2.64, and the specific gravity of the crystal was 2.70, and there was no crystal inside the crystal. A few boas were visible.

〔発明の効果〕〔Effect of the invention〕

比較例1に見られるように、フッ素を含有しないCaO
−Al2O3−P2O6のみの原料混合物では、AhO
3ffiが多いと溶融が不可能であり、比較例2のよう
にフッ素を含有させると溶融は可能であるが、Al2O
3量が多いため一段階で結晶化させるとAl2O3・P
2O5の結晶が十分に生成しないため内部欠陥が生じて
しまう。
As seen in Comparative Example 1, fluorine-free CaO
-In the raw material mixture of only -Al2O3-P2O6, AhO
If 3ffi is too large, melting is impossible, and if fluorine is contained as in Comparative Example 2, melting is possible, but Al2O
Since the amount of 3 is large, if it is crystallized in one step, Al2O3・P
Internal defects occur because 2O5 crystals are not sufficiently produced.

ところが、実施例1にみられるように、本発明のF原子
を含むCaO−Al2O3−PzOs系結晶化ガラスは
内部欠陥もなく、医用材料として最適であることを示し
ている。
However, as seen in Example 1, the CaO-Al2O3-PzOs-based crystallized glass containing F atoms of the present invention has no internal defects, indicating that it is optimal as a medical material.

Claims (1)

【特許請求の範囲】[Claims] CaO10〜60重量%、Al_2O_35〜35重量
%、P_2O_525〜85重量%よりなる組成の原料
混合物にCaO、Al_2O_3およびP_2O_5の
合量100重量部に対しF原子として3重量部以下を添
加し、溶融、鋳造後、ガラス質鋳造体の軟化点とリン酸
カルシウムの結晶化温度との間の温度で次第に温度を上
げながら2段階以上の結晶化処理を行なうことを特徴と
するCaO−Al_2O_3−P_2O_5結晶化ガラ
スの製造方法。
To a raw material mixture having a composition of 10 to 60% by weight of CaO, 35 to 35% by weight of Al_2O_, and 525 to 85% by weight of P_2O, 3 parts by weight or less of F atoms are added to 100 parts by weight of the total amount of CaO, Al_2O_3 and P_2O_5, and melted. After casting, a crystallization treatment of CaO-Al_2O_3-P_2O_5 is performed in two or more stages while gradually increasing the temperature between the softening point of the glassy cast body and the crystallization temperature of calcium phosphate. Production method.
JP60194593A 1985-09-02 1985-09-02 Production of crystallized cao-al2o3-p2o5 glass Pending JPS6256336A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60194593A JPS6256336A (en) 1985-09-02 1985-09-02 Production of crystallized cao-al2o3-p2o5 glass

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60194593A JPS6256336A (en) 1985-09-02 1985-09-02 Production of crystallized cao-al2o3-p2o5 glass

Publications (1)

Publication Number Publication Date
JPS6256336A true JPS6256336A (en) 1987-03-12

Family

ID=16327122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60194593A Pending JPS6256336A (en) 1985-09-02 1985-09-02 Production of crystallized cao-al2o3-p2o5 glass

Country Status (1)

Country Link
JP (1) JPS6256336A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0473048A2 (en) * 1990-08-21 1992-03-04 Asahi Glass Company Ltd. Calcium phosphate type glass-ceramic
CN108275883A (en) * 2018-02-01 2018-07-13 福州瑞克布朗医药科技有限公司 A kind of boron phosphorus system bioactivity glass and preparation method thereof containing aluminium

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0473048A2 (en) * 1990-08-21 1992-03-04 Asahi Glass Company Ltd. Calcium phosphate type glass-ceramic
CN108275883A (en) * 2018-02-01 2018-07-13 福州瑞克布朗医药科技有限公司 A kind of boron phosphorus system bioactivity glass and preparation method thereof containing aluminium
CN108275883B (en) * 2018-02-01 2020-08-04 福州瑞克布朗医药科技有限公司 Aluminum-containing boron-phosphorus bioactive glass and preparation method thereof

Similar Documents

Publication Publication Date Title
US5336642A (en) Canasite-apatite glass-ceramics
JPS6210939B2 (en)
JPS62128947A (en) Cao-al2o3-p2o5 crystallized glass
JPS6256336A (en) Production of crystallized cao-al2o3-p2o5 glass
KR920000150B1 (en) Crystalized glass for human body and preparation method
JPS6256337A (en) Production of crystallized glass of ternary component system of cao-al2o3-p2o5
JPS6236042A (en) Cao-al2o3-p2o5 three-component crystallized glass
KR940003461B1 (en) Method for glass ceramic withused living body material
JPS60137853A (en) High-strength crystallized glass containing apatite crystal and its production
JPS6236031A (en) Production of crystallized cao-al2o3-p2o5 glass
JPS6350344A (en) Glass ceramic composition
JPS6256335A (en) Crystallized cao-al2o3-p2o5 glass
JPS61186247A (en) Crystallized cao-al2o3-p2o5 glass
Kamnoy et al. Effect of Heat Treatment Temperature on the Microstructure and Mechanical Properties of Li2O–SiO2–P2O5–Al2O3–K2O–CaO Glass-Ceramics
JPS6321237A (en) Al2o3-containing cao-p2o5-b2o3-base crystallized glass
JPH0429617B2 (en)
JPS6256334A (en) Production of crystallized cao-al2o3-p2o5 glass
JPS6172638A (en) Production of calcium phosphate-type crystallized glass
JPH0429618B2 (en)
JPS60180931A (en) Low-melting point calcium phosphate glass
Monmaturapoj et al. Effect of Glass Compositions on Crystallization and Mechanical Properties of Lithium Disilicate Glass Ceramics for Dental Crown
JPS60204636A (en) Production of calcium phosphate based dental material
JPS6163540A (en) Preparation of crystallized calcium phosphate glass for dental material
JPS63182228A (en) Method for strengthening calcium phosphate-base crystallizing glass
JPH0249261B2 (en)